145 related articles for article (PubMed ID: 25122866)
21. Are Clostridioides difficile infections being overdiagnosed in hematopoietic stem cell transplant recipients?
Ford CD; Lopansri BK; Coombs J; Webb BJ; Asch J; Hoda D
Transpl Infect Dis; 2020 Aug; 22(4):e13279. PubMed ID: 32196881
[TBL] [Abstract][Full Text] [Related]
22. An Observational Cohort Study of
Rao K; Higgins PDR; Young VB
mSphere; 2018; 3(3):. PubMed ID: 29794054
[TBL] [Abstract][Full Text] [Related]
23. Polymerase chain reaction ribotyping of Clostridium difficile isolates in Qatar: a hospital-based study.
Al-Thani AA; Hamdi WS; Al-Ansari NA; Doiphode SH; Wilson GJ
BMC Infect Dis; 2014 Sep; 14():502. PubMed ID: 25223337
[TBL] [Abstract][Full Text] [Related]
24. The Clinical and Laboratory Impact of Upgrading Clostridioides (formerly Clostridium) difficile Infection Testing from Routine to Molecular Based-Algorithm: an Observational Case-Study from the Eastern Province, Saudi Arabia.
Alnimr A; Alwazzeh MJ; Al-Ameer A
Clin Lab; 2019 Aug; 65(8):. PubMed ID: 31414736
[TBL] [Abstract][Full Text] [Related]
25. Rapid detection assay of toxigenic Clostridioides difficile through PathOC RightGene, a novel high-speed polymerase chain reaction device.
Okanda T; Mitsutake H; Aso R; Sekizawa R; Takemura H; Matsumoto T; Nakamura S
Diagn Microbiol Infect Dis; 2021 Feb; 99(2):115247. PubMed ID: 33188946
[TBL] [Abstract][Full Text] [Related]
26. Clinical characteristics of Clostridium difficile infection in hospitalized patients with antibiotic-associated diarrhea in a university hospital in China.
Zhou FF; Wu S; Klena JD; Huang HH
Eur J Clin Microbiol Infect Dis; 2014 Oct; 33(10):1773-9. PubMed ID: 24820293
[TBL] [Abstract][Full Text] [Related]
27. Three different patterns of positive Clostridium difficile laboratory tests. A comparison of clinical behavior.
Olmedo M; Alcalá L; Valerio M; Marín M; Onori R; Reigadas E; Muñoz P; Bouza E
Diagn Microbiol Infect Dis; 2020 Jul; 97(3):115050. PubMed ID: 32482380
[TBL] [Abstract][Full Text] [Related]
28. Comparison of testing approaches for Clostridium difficile infection at a large community hospital.
Grein JD; Ochner M; Hoang H; Jin A; Morgan MA; Murthy AR
Clin Microbiol Infect; 2014 Jan; 20(1):65-9. PubMed ID: 23521523
[TBL] [Abstract][Full Text] [Related]
29. Screening of
Baron SW; Ostrowsky BE; Nori P; Drory DY; Levi MH; Szymczak WA; Rinke ML; Southern WN
Infect Control Hosp Epidemiol; 2020 Feb; 41(2):149-153. PubMed ID: 31822302
[TBL] [Abstract][Full Text] [Related]
30. Effective utilization of C. difficile PCR and identification of clinicopathologic factors associated with conversion to a positive result in symptomatic patients.
Mostafa ME; Flynn T; Hartley CP; Ledeboer NA; Buchan BW
Diagn Microbiol Infect Dis; 2018 Apr; 90(4):307-310. PubMed ID: 29290473
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of the fully automated BD MAX Cdiff and Xpert C. difficile assays for direct detection of Clostridium difficile in stool specimens.
Dalpke AH; Hofko M; Zorn M; Zimmermann S
J Clin Microbiol; 2013 Jun; 51(6):1906-8. PubMed ID: 23515539
[TBL] [Abstract][Full Text] [Related]
32. Use of multilocus variable number of tandem repeats analysis genotyping to determine the role of asymptomatic carriers in Clostridium difficile transmission.
Curry SR; Muto CA; Schlackman JL; Pasculle AW; Shutt KA; Marsh JW; Harrison LH
Clin Infect Dis; 2013 Oct; 57(8):1094-102. PubMed ID: 23881150
[TBL] [Abstract][Full Text] [Related]
33. Novel immunoassay for diagnosis of ongoing Clostridioides difficile infections using serum and medium enriched for newly synthesized antibodies (MENSA).
Haddad NS; Nozick S; Kim G; Ohanian S; Kraft C; Rebolledo PA; Wang Y; Wu H; Bressler A; Le SNT; Kuruvilla M; Cannon LE; Lee FE; Daiss JL
J Immunol Methods; 2021 May; 492():112932. PubMed ID: 33221459
[TBL] [Abstract][Full Text] [Related]
34. Clinical Outcomes of Treated and Untreated C. difficile PCR-Positive/Toxin-Negative Adult Hospitalized Patients: a Quasi-Experimental Noninferiority Study.
Hogan CA; Hitchcock MM; Frost S; Kapphahn K; Holubar M; Tompkins LS; Banaei N
J Clin Microbiol; 2022 Jun; 60(6):e0218721. PubMed ID: 35611653
[TBL] [Abstract][Full Text] [Related]
35. Clostridium difficile infection: monoclonal or polyclonal genesis?
Hell M; Permoser M; Chmelizek G; Kern JM; Maass M; Huhulescu S; Indra A; Allerberger F
Infection; 2011 Oct; 39(5):461-5. PubMed ID: 21826436
[TBL] [Abstract][Full Text] [Related]
36. Clostridium difficile infection in an endemic setting in the Netherlands.
Hensgens MP; Goorhuis A; van Kinschot CM; Crobach MJ; Harmanus C; Kuijper EJ
Eur J Clin Microbiol Infect Dis; 2011 Apr; 30(4):587-93. PubMed ID: 21194003
[TBL] [Abstract][Full Text] [Related]
37. Identification of
Silva ALO; Marra AR; Martino MDV; Mafra ACCN; Edmond MB; Dos Santos OFP
Biomed Res Int; 2017; 2017():5450829. PubMed ID: 29098156
[TBL] [Abstract][Full Text] [Related]
38. Epidemiology of Clostridium difficile infection in hospitalized adults and the first isolation of C. difficile PCR ribotype 027 in central China.
Zhou Y; Mao L; Yu J; Lin Q; Luo Y; Zhu X; Sun Z
BMC Infect Dis; 2019 Mar; 19(1):232. PubMed ID: 30845918
[TBL] [Abstract][Full Text] [Related]
39. Environmental shedding of toxigenic Clostridioides difficile by asymptomatic carriers: A prospective observational study.
Gilboa M; Houri-Levi E; Cohen C; Tal I; Rubin C; Feld-Simon O; Brom A; Eden-Friedman Y; Segal S; Rahav G; Regev-Yochay G;
Clin Microbiol Infect; 2020 Aug; 26(8):1052-1057. PubMed ID: 31904567
[TBL] [Abstract][Full Text] [Related]
40. Comparison of real-time PCR techniques to cytotoxigenic culture methods for diagnosing Clostridium difficile infection.
Knetsch CW; Bakker D; de Boer RF; Sanders I; Hofs S; Kooistra-Smid AM; Corver J; Eastwood K; Wilcox MH; Kuijper EJ
J Clin Microbiol; 2011 Jan; 49(1):227-31. PubMed ID: 20980562
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
